Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/24212
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 18076/20274 (89%)
造访人次 : 5222719      在线人数 : 567
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/24212


    標題: Design and Synthesis of 6-Substituted Uridine Derivatives as Mechanistic Probes and Potential Chemotherapeutic Agents
    作者: Yu-Chiao Shih (史諭樵)
    Jian-Bang Lin (林建邦)
    Ying-Shun Liao (廖英舜)
    Chen-Chieh Liao (廖振傑)
    Jhih-Li He (何智豐)
    Yuen-Jen Wu (吳元仁)
    Cheng-Hung Jen (任政宏)
    Tun-Cheng Chien (簡敦誠)
    日期: 2011
    上傳時間: 2011-06-23 14:57:06 (UTC+8)
    摘要: Orotidine 5'-monophosphate decarboxylase (ODCase) catalyzes the decarboxylation of orotidine 5'-monophosphate (OMP, 1) to uridine 5'-monophosphate (UMP, 2) in the final step of the de novo pyrimidine nucleotide biosynthesis. ODCase has been identified as a potential target for the new drug discovery. Inhibition of ODCase results in depletion of the pyrimidine nucleceotide pools, which can be correlated to antiviral, antiparasitic, and anticancer activities. ODCase is one of the most proficient enzymes known. Unlike most of the other decarboxylases, ODCase contains no metal ions or small molecule cofactors, and there is no evidence for the existence of a covalent intermediate during the catalysis. These facts suggest that the proficient catalyst operates by a novel chemical mechanism. The research has been focusing on developing effective mechanistic probes to tudy the possible mechanisms for the enzymatic catalysis of ODCase. The research includes the design and synthesis of the structural models (3) of natural and alternative substrates to explore the chemistry occurring at the 6-position of uridine derivatives in order to elucidate the possible enzymatic mechanisms by chemical model reactions. In addition, the research has also investigated the chemistry generally applicable to the modification at the 6-position of uridine to synthesize a series of OMP analogs (4) that were designed by bioisosteric replacement of the characteristic OMP functional group. Our effort toward the synthesis of mechanistic probes for ODCase provided a better understanding of the mechanism of the OMP decarboxylation process. The 6-substituted uridine derivatives are potential ODCase inhibitors as well as chemotherapeutical agents which are currently under evaluation.
    關聯: 2011年台俄有機、藥物與生物化學交流暨藥物化學研討會,起迄日:2011/04/06~2011/04/05,地點:溪頭台大實驗林
    显示于类别:[藥理學院] 2011年台俄有機、藥物與生物化學交流暨藥物化學研討會

    文件中的档案:

    档案 描述 大小格式浏览次数
    il-12.pdf115KbAdobe PDF660检视/开启


    在CNU IR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈